Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Restylane Refyne for Correction of Horizontal Neck Rhytides

NCT: NCT04162496 · COMPLETED

NCT IDNCT04162496
StatusCOMPLETED
Start Date2020-08-11
Completion2021-11-30
SponsorSiperstein Dermatology (OTHER)
First posted
Last updated

Brief Summary

Subjects with grades ranging from 1---3 on the Transverse Neck Line Scale, will be randomized to receive up to 1cc of Restylane Refyne on one side of their neck utilizing a cannula and up to 1cc of Restylane Refyne on the other side utilizing a 30--gauge needle. On Day 30, this treatment with the same left---right assignment can be repeated if optimal correction on either side has not been achieved according to the treating investigator. Subjects will return 24--48 hours after their first treatment, to fill out questionnaires, take pictures, and to be assessed by blinded evaluators regarding adverse events. Subjects will also return 30 days after their final treatment to fill out final questionnaires, take pictures, and to be assessed by blinded evaluators regarding improvement of static rhytides.

Frequently Asked Questions

What is Restylane Refyne for Correction of Horizontal Neck Rhytides?

Restylane Refyne for Correction of Horizontal Neck Rhytides is a clinical trial registered under NCT04162496. Current status: COMPLETED.

What is the status of NCT04162496?

The current status of NCT04162496 (Restylane Refyne for Correction of Horizontal Neck Rhytides) is: COMPLETED.

When did Restylane Refyne for Correction of Horizontal Neck Rhytides start?

Restylane Refyne for Correction of Horizontal Neck Rhytides started on 2020-08-11.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.